Home  »  Business   »  Before Buying Kronos Bio Inc. (NASDAQ: KRON) Stock...

Before Buying Kronos Bio Inc. (NASDAQ: KRON) Stock, Read This First

Kronos Bio Inc. (NASDAQ:KRON) shares, rose in value on Friday, 05/13/22, with the stock price down by -2.25% to the previous day’s close as strong demand from buyers drove the stock to $3.91.

Actively observing the price movement in the last trading, the stock closed the session at $4.00, falling within a range of $3.78 and $4.19. Referring to stock’s 52-week performance, its high was $28.42, and the low was $3.87. On the whole, KRON has fluctuated by -38.91% over the past month.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.

Sponsored

With the market capitalization of Kronos Bio Inc. currently standing at about $238.51 million, investors are eagerly awaiting this quarter’s results, scheduled for Mar 21, 2022 – Mar 25, 2022. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$1.1, which is expected to increase to -$0.65 for fiscal year -$2.72 and then to about -$3.08 by fiscal year 2022. Data indicates that the EPS growth is expected to be 49.90% in 2022, while the next year’s EPS growth is forecast to be -13.20%.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that KRON’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of KRON currently trading nearly -21.25% and -37.90% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 27.40, while the 7-day volatility ratio is showing 9.84% which for the 30-day chart, stands at 8.94%. Furthermore, Kronos Bio Inc. (KRON)’s average true range (ATR) is 0.45.

Data on historical trading for Kronos Bio Inc. (NASDAQ:KRON) indicates that the trading volumes over the past 3 months, they’ve averaged 328.10K. According to company’s latest data on outstanding shares, there are 55.84 million shares outstanding.

Nearly 2.70% of Kronos Bio Inc.’s shares belong to company insiders and institutional investors own 68.50% of the company’s shares. The stock has fallen by -71.23% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the KRON stock heading into the next quarter.

Leave a Comment

Your email address will not be published.

Related Videos

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam